文献速递血栓与止血

抗整合素αvβ3自身抗体通过阻断巨核细胞迁移和黏附导致血小板减少

Autoantibody against integrin αv β3 contributes to thrombocytopenia by blocking the migration and adhesion of megakaryocytes.
PubMed 文献 · J Thromb Haemost · 2018-07-20

该研究探讨抗αvβ3整合素自身抗体在慢性免疫性血小板减少症(ITP)中的作用及机制。体外实验显示该抗体不影响巨核细胞存活与增殖,但显著减少前血小板形成,并阻碍SDF-1α介导的迁移及巨核细胞对内皮细胞和纤维蛋白原的黏附;ITP小鼠模型中注射抗αv抗体延迟血小板恢复。

要点

  • 慢性ITP患者中抗αvβ3自身抗体常与抗αIIbβ3自身抗体共存,双抗体阳性者血小板更低。
  • 抗αvβ3抗体体外不影响巨核细胞存活与增殖,但显著减少前血小板形成。
  • 抗αvβ3抗体阻碍SDF-1α介导的巨核细胞迁移并抑制蛋白激酶B磷酸化。

核心结论

  • 抗整合素αvβ3自身抗体可能通过阻碍巨核细胞迁移和黏附至血管龛而加重ITP患者的血小板减少,为ITP发病机制提供新见解。

研究设计与样本

  • 评估慢性ITP患者抗αvβ3自身抗体水平与血小板的关系,并体外观察该抗体对巨核细胞存活、分化、迁移和黏附的影响及相关信号通路。
  • 在预处理不同抗体的ITP小鼠模型中观察血小板恢复和巨核细胞分布。

主要发现

  • 慢性ITP患者中抗αvβ3自身抗体通常与抗αIIbβ3自身抗体共存,且双抗体阳性者血小板更低。
  • 体外实验中抗αvβ3抗体对巨核细胞存活和增殖无显著影响,但显著减少前血小板形成。
  • 抗αvβ3抗体阻碍SDF-1α介导的迁移并抑制蛋白激酶B磷酸化。
  • 抗αvβ3抗体显著抑制巨核细胞对内皮细胞和纤维蛋白原的黏附,并抑制黏附诱导的黏着斑激酶和原癌基因酪氨酸蛋白激酶Src磷酸化。
  • ITP小鼠模型中注射抗αv抗体延迟血小板恢复。

关键数值与推荐

  • 慢性ITP患者中抗αvβ3自身抗体常与抗αIIbβ3自身抗体共存,双抗体阳性者血小板更低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials The pathogenesis of immune thrombocytopenia (ITP) has not been fully clarified. We analyzed the role of anti-αvβ3 autoantibody in the pathogenesis of ITP in patients. Anti-αvβ3 autoantibody impeded megakaryocyte migration and adhesion to the vascular niche. Anti-αv β3 autoantibody potentially contributes to the pathogenesis of refractory ITP. SUMMARY: Background The pathogenesis of immune thrombocytopenia (ITP) has not been fully clarified. Anti-αvβ3 integrin autoantibody is detected in chronic ITP patients, but its contribution to ITP is still unclear. Objectives To clarify the potential role of anti-αvβ3 integrin autoantibody in chronic ITP and the related mechanism. Methods Relationship between levels of anti-αvβ3 autoantibody and platelets in chronic ITP patients was evaluated. The influence of anti-αvβ3 antibody on megakaryocyte (MK) survival, differentiation, migration and adhesion was assessed, and the associated signal pathways were investigated. Platelet recovery and MKs' distribution were observed in an ITP mouse model pretreated with different antibodies. Result In this study, we showed that the anti-αvβ3 autoantibody usually coexists with anti-αIIbβ3 autoantibody in chronic ITP patients, and patients with both autoantibodies have lower platelets. In in vitro studies, we showed that the anti-αvβ3 antibody had no significant effect on the survival and proliferation of MKs, whereas it decreased formations of proplatelet significantly. Anti-αvβ3 antibody impeded stromal cell derived facor-1 alpha (SDF-1α)- mediated migration and inhibited the phosphorylation of protein kinase B. Anti-αvβ3 antibody significantly inhibited MKs' adhesion to endothelial cells and Fibrogen. The phosphorylation of focal adhesion kinase and proto-oncogene tyrosine-protein kinase Src induced by adhesion was inhibited when MKs were pretreated with anti-αvβ3 antibody. In in vivo studies, we showed that injection with anti-αv antibody delayed platelet recovery in a mouse model of ITP. Conclusions These findings demonstrate that the autoantibody against integrin αv β3 may aggravate thrombocytopenia in ITP patients by impeding MK migration and adhesion to the vascular niche, which provides new insights into the pathogenesis of ITP.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Zeng DF, Chen F, Wang S, et al. Autoantibody against integrin αv β3 contributes to thrombocytopenia by blocking the migration and adhesion of megakaryocytes. J Thromb Haemost. 2018. PMID: 29953749. doi:10.1111/jth.14214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。